About Us

Headquartered in Austin, Texas, Inova Labs Inc. develops and commercializes innovative products for patients with respiratory conditions. Inova Labs is fully ISO 13485 certified, utilizing state-of-the-art manufacturing systems and facilities. Product offerings include the FDA-cleared LifeChoice® and LifeChoice Activox™ Portable Oxygen Concentrators. Inova Labs’ portable oxygen concentrators feature unique Auto Mode and PULSE-WAVE™ Technologies enabling 24/7 use by patients. Both portable oxygen concentrators are FAA-approved for in-flight use.

At Inova Labs, our mission is to help patients with respiratory conditions Stay Active and Sleep Well.

Headquarters
Inova Labs, Inc.
3500 Comsouth Drive, Suite 100
Austin, TX 78744
1.512.617.1700
info@inovalabs.com
 
 

John Rush, CEO, Inova Labs, Inc.

John Rush has more than 28 years of experience in the medical device sector, and joined Inova Labs as Chief Executive Officer in 2011. Previously, Mr. Rush served as Chief Executive Officer of U.K. – based Lombard Medical Technologies PLC, a medical device company for the abdominal aortic aneurysm repair market, from 2009 to early 2011. Currently, Mr. Rush also serves as Non-executive Chairman of the Lombard Medical Board of Directors. During his tenure at Lombard, the Company has successfully navigated through an IDE PMA trial in the United States which led to FDA approval for it’s AAA stent graft in early 2013. Before joining Lombard, Mr. Rush was President and CEO of North American Scientific, Inc. (NASDAQ: NASM) where he re-organized the company and led an investor group initiative to take part of the company private. Rush also served as President and CEO of MicroTherapeutics, Inc. (NASDAQ:MTIX), an interventional neuroradiology company with operations in the United States and Europe. He orchestrated a successful sale of the company to ev3. Prior to MTIX, Rush spent 10 years with Scimed Life Systems/Boston Scientific in various management roles, including General Manager of Boston Scientific’s Asia Pacific business based in Singapore. Mr. Rush has extensive domestic and international experience, with a core sales and marketing background.John Rush, CEO, Inova Labs, Inc.

William R. Wilkinson Founder, Inova Labs, Inc.

William R. Wilkinson co-founded Inova Labs in 2002 and has served as Vice President of Research and Development since then. He was also a co-founder of International Biophysics Corporation (IBC) in 1992 and serves as its Vice President of Research and Development. Inova Labs was an affiliate company of IBC and is now a fully independent company. Wilkinson’s responsibilities for both Inova Labs and IBC include all research, engineering and manufacturing functions. In addition, he has designed and developed several hundred medical products in the fields of cardiovascular surgery, laparoscopic surgery, nutritional delivery systems, respiratory therapies, audiology, kidney dialysis, gynecology, oncology and dermatology. He is a listed inventor on more than 50 patents in the U.S. and other countries. Prior to forming IBC, Wilkinson held senior-level technical roles with Baxter Laboratories and C.R. Bard. He also held various technical, sales, marketing and general management positions with several other medical companies, including William Harvey Research, Gish Biomedical, Texas Medical Products, Wilcour Engineering, Omega Pharmaceuticals and CardioMetrics, for which he was a founder. He is a registered professional engineer in California as well as an ASQC Certified Quality Engineer. Wilkinson received a Bachelor of Arts in Zoology from the University of California, Los Angeles. He also studied oceanography at the graduate level at San Diego State University and participated in the Doctor of Science program in Pharmaco Dynamics at Hatfield Polytech, Cambridge University and the Master of Business Administration program at Northrup University.

Richard Lin Partner, Three Arch Partners

Rich Lin joined Three Arch Partners in 1988. Prior to Three Arch, Lin trained in general surgery at the University of California, San Francisco. He was also a research scientist at the UCSF School of Medicine and Harvard Medical School where he authored numerous peer reviewed articles and abstracts. Lin has been an active investor and board member in numerous biotechnology, healthcare service, and medical device companies. Lin has a BS in Biology from Stanford University where he graduated with honors and was a member of the Phi Beta Kappa honor society. He has an MD from Harvard Medical School where he graduated cum laude. While at Harvard, Lin was named a Howard Hughes Scholar for his research efforts. He also has an MBA from the Stanford Graduate School of Business where he was named an Arjay Miller Scholar for outstanding academic achievement.

Steve Salmon Partner, Latterell Venture Partners

Stephen Salmon is a seasoned medical device professional bringing over 20 years of product development and management experience to LVP. Salmon has held several executive and R&D management positions within both large public medical device companies and small medical device startups, including Engineering Manager with CVIS (acquired by Boston Scientific), VP R&D with Boston Scientific, Co-Founder and VP Operations of Integrated Vascular Systems (acquired by Abbott), and Co-Founder of Ensure Medical (acquired by JNJ). His device experience is broad, spanning products in interventional cardiology, neurovascular, peripheral vascular, gastrointestinal, orthopedic, cardiac and vascular surgery. During his tenure in the medical device industry, Salmon has authored or co-authored 18 U.S. patents, with several additional patents pending. He holds a B.S. in Chemical Engineering from the University of Maine.

Geoff Pardo Partner, Gilde Healthcare Partners

Geoff Pardo joined Gilde in 2011 as a Partner and is responsible for Gilde’s US office in Boston/Cambridge, MA and for investments in North America. He led the investment in Inova Labs, Inc. and represents Gilde as a member of its board of directors. Previously, Pardo was a Partner at Spray Venture Partners where he led investments into Interlace Medical (sold to Hologic), Solace Therapeutics, TearScience and Cascade Ophthalmics. He served on the board of Solace, TearScience and Cascade, and was actively involved in Interlace and Conventus Orthopedics.He also served as President and CEO of Facet Solutions, a spinal implant company focused on treating lumbar spinal stenosis until the company was sold to Globus Medical in 2011. He has also worked at Cardinal Partners as an Associate leading their investing activity in the medical device sector. He was responsible for sourcing and managing investments in Replication Medical and CardioOptics. Pardo began his career in medical devices as a product manager with Synthes USA. While there he led the market introduction of a bone graft substitute which was named Synthes’ impact product of the year in 1999. He has a B.A. with honors in History from Brown University and an M.B.A. from the Wharton School of Business. He is a US citizen based in Gilde’s Cambridge, MA office.

Rod Young Venture Partner, Three Arch Partners

Rod Young joined Three Arch Partners as a Venture Partner in May 2006. Prior to Three Arch Partners, Young was President and CEO of Vivant Medical, a Three Arch Partners medical device company that was acquired by Tyco, President & CEO of Targesome, Chairman & CEO of General Surgical Innovations, also a Three Arch Partners medical device company that was acquired by Tyco, President & CEO of Focus Surgery, President of Toshiba America MRI, and President & COO of Diasonics. Young holds a BS degree in Industrial Engineering from Stanford University and an MBA from the Harvard Business School.

John Rush, CEO, Inova Labs, Inc.

John Rush has more than 28 years of experience in the medical device sector, and joined Inova Labs as Chief Executive Officer in 2011. Previously, Mr. Rush served as Chief Executive Officer of U.K. – based Lombard Medical Technologies PLC, a medical device company for the abdominal aortic aneurysm repair market, from 2009 to early 2011. Currently, Mr. Rush also serves as Non-executive Chairman of the Lombard Medical Board of Directors. During his tenure at Lombard, the Company has successfully navigated through an IDE PMA trial in the United States which led to FDA approval for it’s AAA stent graft in early 2013. Before joining Lombard, Mr. Rush was President and CEO of North American Scientific, Inc. (NASDAQ: NASM) where he re-organized the company and led an investor group initiative to take part of the company private. Rush also served as President and CEO of MicroTherapeutics, Inc. (NASDAQ:MTIX), an interventional neuroradiology company with operations in the United States and Europe. He orchestrated a successful sale of the company to ev3. Prior to MTIX, Rush spent 10 years with Scimed Life Systems/Boston Scientific in various management roles, including General Manager of Boston Scientific’s Asia Pacific business based in Singapore. Mr. Rush has extensive domestic and international experience, with a core sales and marketing background.John Rush, CEO, Inova Labs, Inc.

Dr. Dragan D. Nebrigic Chief Technology Officer

In January 2013 Dr. Nebrigic is appointed Chief Technology Officer where he was holding position, Vice President Product Development, since February 2012. Dr. Nebrigic brings to Inova Labs more than 20 years of experience in medical devices and biotechnologies. He holds over 40 US and International Patents in the area of medical devices, consumer electronics and medical sensor technologies. Prior to working at Inova Labs, Dr. Nebrigic served as Vice President of Research and Development with Thermage, as well as Vice President of Research and Development with Solta Medical. He also held the position of Senior Director of Global Advanced Technologies and Intellectual Property with Maxwell Technologies and served as the Executive Director of Engineering and Advanced Technologies with the American Technology Corporation and Molecular Reflections Corporation. During his tenure with Procter and Gamble from 1996 until 2000, Dr. Nebrigic spearheaded efforts related to novel portable energy sources as well as new consumer biosensor and portable medical devices applications. Dr. Nebrigic also held an adjunct Professor position of Electrical Engineering with the University of Cincinnati. Dr. Nebrigic holds a M.S. in Electrical and Computer Engineering and Technical Physics from the University of Belgrade Serbia and Ph.D. in Electrical and Computer Engineering from the University of Cincinnati.

Dan Jensen Chief Financial Officer

Dan Jensen was named Inova Labs’ Vice President of Finance in September 2012 and CFO in October 2013. Prior to joining Inova Labs, Jensen held a variety of leadership positions at Advanced Micro Devices, Freescale Semiconductor, Motorola and Coopers & Lybrand, and Pricewaterhouse Coopers. Jensen has over 23 years’ experience in strategy, finance, and operations including two years in Toronto Canada responsible for the AMD’s Graphics Products Group, two years in Beijing China responsible for AMD’s Greater China Region, and two-and-a-half years in Tianjin, China with Motorola’s Semiconductor Products Sector as the China Country Controller. He holds dual degrees in Accounting and Management Information Systems from the University of Wisconsin – Oshkosh and is a Certified Public Accountants and previously was a Certified Information Systems Auditor. Dan is responsible for Finance, Legal, Information Technology and Facilities functions.

Phil Martin Vice President, Sales

Phil Martin has extensive experience in the medical device industry. Prior to joining Inova Labs as Vice President of Sales in 2011, Martin served as Vice President of Sales and Interventional Cardiology for Boston Scientific Corporation in Minneapolis, MN from 2003 to 2010. During that time, Martin oversaw and was accountable for $700 million annual sales plans of interventional cardiology and peripheral vascular products. Martin was also Director of Interventional Cardiology for Boston Scientific Corporation in New York, NY from 1994 to 2003. Martin holds a Bachelor of Science degree in business management from Alfred University in Alfred, NY.

Ron Yarbrough Vice President, Regulatory Affairs and Quality Assurance

Ron Yarbrough joined Inova Labs as Vice President of RAQA in July of 2013. Prior to joining Inova Labs, Yarbrough served as Director of Regulatory Affairs and prior to that as Director of Quality Assurance for Zimmer Spine based in Minneapolis, MN. Ron has held a variety of positions with increasing responsibility at Zimmer Spine, Abbott Laboratories, Zimmer Orthopedics, Centerpulse, Sulzer, and Intermedics and worked in a variety of functions, including Product Development, Operations, Quality Assurance, and Regulatory Affairs management. Yarbrough has over 15 years of extensive experience in the medical device industry dealing with a variety of Class I, II, and III products, as well as tissue banking. He has created and executed strategies to obtain predictable global product approvals and significantly improve product quality by implementing enhanced design controls and advanced production/process controls. Rising quickly from a top technical contributor to a position as divisional Director of Quality Assurance and then Regulatory Affairs, Ron’s organizations led companies to establish world-class quality systems and successfully resolve chronic problems. Ron is responsible for all global regulatory and quality activities for the company and functions as the management representative for Inova Labs. Ron holds a Bachelor of Science degree in industrial technology from Texas State University.

Keith James Vice President, Marketing

Keith James joined Inova Labs in January 2014 bringing over 19 years of experience in the respiratory care and medical device industries. Prior to joining Inova Labs, Keith was the Director of Marketing and Sales for Breathe Technologies. During that time, James developed and implemented the marketing and sales launch plan for a portable non-invasive open ventilation system (NIOV). James also worked for such companies as Carefusion, Wright Medical, and Transonic Systems. James is a Registered Respiratory Therapist, holds a Masters in Business Administration, and a Bachelor of Science in Management Information Systems from California State University, Chico.